<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vorup-Jensen T</submitter><funding>NCI NIH HHS</funding><pagination>1873-8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC149926</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>100(4)</volume><pubmed_abstract>The integrin alpha X beta 2 (CD11c/CD18, p150,95) binds ligands through the I domain of the alpha X subunit. Ligands include the complement factor fragment iC3b, a key component in the innate immune defense, which, together with the expression of alpha X beta 2 on dendritic cells and on other leukocytes, suggests a role in the immune response. We now report the structure of the alpha X I domain resolved at 1.65 A by x-ray crystallography. To analyze structural requirements for ligand binding we made a mutation in the alpha X I domain C-terminal helix, which increased the affinity for iC3b approximately 200-fold to 2.4 microM compared with the wild-type domain affinity of approximately 400 microM. Gel permeation chromatography supported a conformational change between the wild-type and mutated domains. Conservation of allosteric regulation in the alpha X I domain points to the functional importance of this phenomenon.</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Structure and allosteric regulation of the alpha X beta 2 integrin I domain.</pubmed_title><pmcid>PMC149926</pmcid><funding_grant_id>R01 CA031799</funding_grant_id><funding_grant_id>CA31799</funding_grant_id><pubmed_authors>Springer TA</pubmed_authors><pubmed_authors>Vorup-Jensen T</pubmed_authors><pubmed_authors>Ostermeier C</pubmed_authors><pubmed_authors>Shimaoka M</pubmed_authors><pubmed_authors>Hommel U</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structure and allosteric regulation of the alpha X beta 2 integrin I domain.</name><description>The integrin alpha X beta 2 (CD11c/CD18, p150,95) binds ligands through the I domain of the alpha X subunit. Ligands include the complement factor fragment iC3b, a key component in the innate immune defense, which, together with the expression of alpha X beta 2 on dendritic cells and on other leukocytes, suggests a role in the immune response. We now report the structure of the alpha X I domain resolved at 1.65 A by x-ray crystallography. To analyze structural requirements for ligand binding we made a mutation in the alpha X I domain C-terminal helix, which increased the affinity for iC3b approximately 200-fold to 2.4 microM compared with the wild-type domain affinity of approximately 400 microM. Gel permeation chromatography supported a conformational change between the wild-type and mutated domains. Conservation of allosteric regulation in the alpha X I domain points to the functional importance of this phenomenon.</description><dates><release>2003-01-01T00:00:00Z</release><publication>2003 Feb</publication><modification>2024-12-03T21:52:50.952Z</modification><creation>2019-10-26T17:17:45Z</creation></dates><accession>S-EPMC149926</accession><cross_references><pubmed>12554829</pubmed><doi>10.1073/pnas.0237387100</doi></cross_references></HashMap>